ABA Chemicals Corporation carries a market capitalization of 4.43B, placing it among publicly traded companies globally. Its enterprise value stands at 7.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.43B |
| Enterprise Value | 7.87B |
ABA Chemicals Corporation currently has 963.31M shares outstanding.
| Shares Outstanding | 963.31M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 5.34, and the price-to-book ratio stands at 5.49.
| PE Ratio | N/A |
| PS Ratio | 5.34 |
| PB Ratio | 5.49 |
| P/TBV Ratio | 4.03 |
| P/FCF Ratio | 50.06 |
| P/OCF Ratio | N/A |
| EV / Sales | 6.17 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 48.32 |
ABA Chemicals Corporation maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 60.26, indicating elevated leverage, while an interest coverage ratio of -3.60 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.93 |
| Quick Ratio | 0.21 |
| Debt / Equity | 60.26 |
| Debt / EBITDA | -11.34 |
| Interest Coverage | -3.60 |
| Return on Equity (ROE) | -15.63 |
| Return on Assets (ROA) | -5.19 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.25 |
| Income Tax | -39.62M |
| Effective Tax Rate | N/A |
ABA Chemicals Corporation's stock has declined approximately -35.75419% over the past 52 weeks. The 50-day moving average sits at 5.23, while the 200-day moving average is 6.59.
| Beta (5Y) | N/A |
| 52-Week Price Change | -35.75419% |
| 50-Day Moving Average | 5.23 |
| 200-Day Moving Average | 6.59 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, ABA Chemicals Corporation generated 1.27B in revenue and converted that into -214.36M in net income, yielding earnings per share of -0.24. EBITDA reached -113.63M, while operating income came in at -113.63M.
| Revenue | 1.27B |
| Gross Profit | 208.88M |
| Operating Income | -113.63M |
| Pretax Income | -266.60M |
| Net Income | -214.36M |
| EBITDA | -113.63M |
| EBIT | -113.63M |
| Earnings Per Share (EPS) | -0.24 |
ABA Chemicals Corporation holds 352.99M in cash and equivalents against 1.29B in total debt, resulting in a net debt position of 815.38M. Total book value stands at 1.24B, with working capital of -122.62M providing operational flexibility.
| Cash & Cash Equivalents | 352.99M |
| Total Debt | 1.29B |
| Net Debt | 815.38M |
| Equity (Book Value) | 1.24B |
| Book Value Per Share | 1.30 |
| Working Capital | -122.62M |
After subtracting -135.98M in capital expenditures, free cash flow totaled -135.98M - equivalent to -0.14 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -135.98M |
| Free Cash Flow | -135.98M |
| FCF Per Share | -0.14 |
ABA Chemicals Corporation operates with a gross margin of 16.39, reflecting its pricing power and cost economics. The operating margin of -8.91 and net profit margin of -16.82 provide insight into operational efficiency.
| Gross Margin | 16.39 |
| Operating Margin | -8.91 |
| Pretax Margin | -20.92 |
| Profit Margin | -16.82 |
| EBITDA Margin | -8.91 |
The company's payout ratio of -33.40 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.08 |
| Dividend Yield | N/A |
| Payout Ratio | -33.40 |
| Shareholder Yield | -0.69 |
| FCF Yield | 2.00 |
ABA Chemicals Corporation's most recent stock split took place on June 21, 2018 with a 2:3 split ratio.
| Last Split Date | 6/21/2018 |
| Split Ratio | 2:3 |
ABA Chemicals Corporation posts an Altman Z-Score of 2.40, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.40 |